Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A new platelet preservative.

Daniel Ericson1, Krzysztof Karnicki, Clarence Johnson

  • 1Viacell, LLC, Rochester, MN, USA. danericson@subinc.com

Platelets
|December 19, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Embracing the Multifaceted Roles of Biomolecules in Biology and Medicine.

Biomolecules·2025
Same author

Inflammation: Is It a Healer, Confounder, or a Promoter of Cardiometabolic Risks?

Biomolecules·2024
Same author

Editorial: Insights in diabetes: molecular mechanisms 2022.

Frontiers in endocrinology·2023
Same author

Coronavirus Disease and Acute Vascular Events.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2020
Same author

Intron-specific Single Nucleotide Polymorphisms of Fat Mass and Obesity- Associated Gene in Obese and Overweight Individuals of the Indian Adult Population- A Pilot Study.

Current diabetes reviews·2019
Same author

MnO<sub>2</sub> Nanotube-Based NanoSearchlight for Imaging of Multiple MicroRNAs in Live Cells.

ACS applied materials & interfaces·2017

A novel platelet preservative, ViaCyte, better protects platelets from storage-induced damage compared to the standard citrate-phosphate-dextrose (CPD) solution. This preserves platelet function and availability for transfusion.

Area of Science:

  • Biomedical Engineering
  • Hematology
  • Transfusion Medicine

Background:

  • Platelet storage solutions are crucial for maintaining platelet viability and function.
  • Current storage solutions, like citrate-phosphate-dextrose (CPD), may not fully prevent storage-induced platelet activation and dysfunction.
  • Impaired platelet function can negatively impact hemostasis, clot retraction, and wound healing.

Purpose of the Study:

  • To evaluate the efficacy of a new platelet preservative, ViaCyte, in protecting platelets against storage-induced activation.
  • To compare the protective effects of ViaCyte with the standard CPD storage solution.
  • To assess the impact of storage solutions on platelet function and resting state.

Main Methods:

  • Platelets were stored for five days at room temperature in either ViaCyte or CPD.

Related Experiment Videos

  • P-selectin expression (a marker of platelet activation) was measured at rest.
  • Platelet activation was assessed upon stimulation with thrombin.

    • Main Results:

    • Platelets stored in ViaCyte showed significantly lower resting P-selectin expression (12.2%) compared to CPD (44.4%).
    • Upon thrombin challenge, ViaCyte-stored platelets showed a preserved response (64.2% activation), while CPD-stored platelets had a limited increase (47.9% activation).
    • ViaCyte maintained the resting state and preserved platelet function, unlike CPD which led to storage-induced lesions.

    Conclusions:

    • ViaCyte offers superior protection for platelets during storage compared to CPD.
    • The standard CPD solution does not adequately protect platelets from storage-induced dysfunction.
    • Preserving platelet function through improved storage solutions is vital for effective hemostasis and therapeutic outcomes.